What does CUSIP 10778Y302 represent in this 13F holders report?

CUSIP 10778Y302 is the security identifier for BCTX - BRIACELL THERAPEUTICS CORP - COM NEW used to aggregate holder disclosures.

How many institutions held BCTX - BRIACELL THERAPEUTICS CORP - COM NEW in Q2 2021?

22 institutional investors reported BCTX - BRIACELL THERAPEUTICS CORP - COM NEW for Q2 2021. Use the holders table for investor-level position and value details.

BRIACELL THERAPEUTICS CORP - COM NEW (BCTX)

CUSIP: 10778Y302

Q2 2021 13F Holders as of 30 Jun 2021

Security type / class: Equity / COM NEW
Total 13F shares: 3,801,628
Total 13F value: $20,265,000
Share change: +3,176,426
SEC-reported price per share: $5.33
Number of holders: 22
Value change: +$17,029,576
Number of buys: 19
Number of sells: 3

Security key

10778Y302

Report period

Q2 2021

Institutions

Top holders

BCTX full security history Ownership snapshot Full 13F holder table BriaCell Therapeutics Corp. SEC filings BriaCell Therapeutics Corp. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BCTX - BRIACELL THERAPEUTICS CORP - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

SABBY MANAGEMENT, LLC

Disclosed value leader

SABBY MANAGEMENT, LLC

Comparable rows

0/12

Latest evidence

31 Mar 2021

13F Highest disclosed value: $618,000 12 rows are not safely comparable across share classes. Showing 1-6 of 12 holder rows.

Quick read

SABBY MANAGEMENT, LLC has the largest disclosed position value at $618K.

0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SABBY MANAGEMENT, LLC's linked filing trail.

Disclosed position value Top 5

SABBY MANAGEMENT, LLC $618K

Redmond Asset Management, LLC $588K

Altium Capital Management LLC $535K

ARMISTICE CAPITAL, LLC $450K

ZEKE CAPITAL ADVISORS, LLC $222K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 12 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SABBY MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$618,000 160,182 shares	—	31 Mar 2021
Redmond Asset Management, LLC	13F Company 13F	— mixed-class rows	$588,000 206,731 shares mixed-class rows	—	31 Mar 2021
Altium Capital Management LLC	13F Company 13F	— denominator unverified	$535,000 500,000 shares	—	31 Mar 2021
ARMISTICE CAPITAL, LLC	13F Company 13F	— denominator unverified	$450,000 420,536 shares	—	31 Mar 2021
ZEKE CAPITAL ADVISORS, LLC	13F Company 13F	— mixed-class rows	$222,000 90,000 shares mixed-class rows	—	31 Mar 2021
Warberg Asset Management LLC	13F Company 13F	— denominator unverified	$64,000 59,400 shares	—	31 Mar 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,801,628

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 value	Q2 2021 value	Value change	Value Chg %